Advances in Genetic Testing in Patients With Breast Cancer, High-Quality Decision Making, and Responsible Resource Allocation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.Gynecologic oncology · 2021
   Pooled it
2. A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer.Breast cancer research and treatment · 2020
   Pooled it
3. Machine learning model for predicting epidermal growth factor receptor expression status in breast cancer using ultrasound radiomics.Frontiers in oncology · 2025
   Article
4. Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
   Article
5. Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.Annals of surgical oncology · 2023
   Article
6. Involvement in treatment decision-making and self-reported efficacy among patients with advanced colorectal cancer: a nationwide multi-center cross-sectional study.Frontiers in oncology · 2023
   Article
7. Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer.JCO precision oncology · 2022
   Article
8. DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data.Genome medicine · 2022
   Article
9. Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.Annals of surgical oncology · 2022
   Article
10. Treatment Options for GermlineJournal of the advanced practitioner in oncology · 2021
    Review
11. Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing.Breast cancer research and treatment · 2020
    Article
12. Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Article
13. Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience.Cancers · 2020
    Article
14. The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Article

Corrections and comments

• Comment on
  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as